Corteva annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Corteva Revenue Growth & History (CTVA)
Corteva reported $17.40B in revenue for fiscal 2025, an increase of 2.92% from the previous fiscal year.
View full Corteva company overviewCorteva annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $17.40B | $493.0M | +2.92% |
| 2024 | 2024-12-31 | $16.91B | −$318.0M | −1.85% |
| 2023 | 2023-12-31 | $17.23B | −$229.0M | −1.31% |
| 2022 | 2022-12-31 | $17.45B | $1.80B | +11.50% |
| 2021 | 2021-12-31 | $15.65B | $1.44B | +10.11% |
| 2020 | 2020-12-31 | $14.22B | $371.0M | +2.68% |
| 2019 | 2019-12-31 | $13.85B | −$441.0M | −3.09% |
| 2018 | 2018-12-31 | $14.29B | — | — |
Corteva quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.38B | −$77.0M | −1.19% |
| Q1 2026 | 2026-03-31 | $4.91B | $488.0M | +11.05% |
| Q4 2025 | 2025-12-31 | $3.91B | −$68.0M | −1.71% |
| Q3 2025 | 2025-09-30 | $2.62B | $292.0M | +12.55% |
| Q2 2025 | 2025-06-30 | $6.46B | $344.0M | +5.63% |
| Q1 2025 | 2025-03-31 | $4.42B | −$75.0M | −1.67% |
| Q4 2024 | 2024-12-31 | $3.98B | $271.0M | +7.31% |
| Q3 2024 | 2024-09-30 | $2.33B | −$264.0M | −10.19% |
| Q2 2024 | 2024-06-30 | $6.11B | $67.0M | +1.11% |
| Q1 2024 | 2024-03-31 | $4.49B | −$392.0M | −8.03% |
| Q4 2023 | 2023-12-31 | $3.71B | −$118.0M | −3.08% |
| Q3 2023 | 2023-09-30 | $2.59B | −$187.0M | −6.73% |
| Q2 2023 | 2023-06-30 | $6.04B | −$207.0M | −3.31% |
| Q1 2023 | 2023-03-31 | $4.88B | $283.0M | +6.15% |
| Q4 2022 | 2022-12-31 | $3.83B | $346.0M | +9.95% |
| Q3 2022 | 2022-09-30 | $2.78B | $406.0M | +17.12% |
| Q2 2022 | 2022-06-30 | $6.25B | $625.0M | +11.11% |
| Q1 2022 | 2022-03-31 | $4.60B | $423.0M | +10.12% |
| Q4 2021 | 2021-12-31 | $3.48B | $272.0M | +8.48% |
| Q3 2021 | 2021-09-30 | $2.37B | $508.0M | +27.27% |
| Q2 2021 | 2021-06-30 | $5.63B | $436.0M | +8.40% |
| Q1 2021 | 2021-03-31 | $4.18B | $222.0M | +5.61% |
| Q4 2020 | 2020-12-31 | $3.21B | $224.0M | +7.51% |
| Q3 2020 | 2020-09-30 | $1.86B | −$48.0M | −2.51% |
| Q2 2020 | 2020-06-30 | $5.19B | −$365.0M | −6.57% |
| Q1 2020 | 2020-03-31 | $3.96B | $560.0M | +16.49% |
| Q4 2019 | 2019-12-31 | $2.98B | $168.0M | +5.97% |
| Q3 2019 | 2019-09-30 | $1.91B | −$36.0M | −1.85% |
| Q2 2019 | 2019-06-30 | $5.56B | −$175.0M | −3.05% |
| Q1 2019 | 2019-03-31 | $3.40B | −$398.0M | −10.49% |
| Q4 2018 | 2018-12-31 | $2.81B | — | — |
| Q3 2018 | 2018-09-30 | $1.95B | — | — |
| Q2 2018 | 2018-06-30 | $5.73B | — | — |
| Q1 2018 | 2018-03-31 | $3.79B | — | — |
Corteva revenue growth trends
Over the last five reported fiscal years, revenue grew from $14.22B to $17.40B, a compound annual growth rate of 4.12%. Corteva's latest reported quarter, Q2 2026, generated $6.38B in revenue, a decrease of 1.19% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Corteva source filings ↗Community posts
Corteva settles Inari seed-IP case, with licensing talks still pending
Corteva ($CTVA) and Inari have reached a confidential settlement of Corteva’s seed-related intellectual-property lawsuit in Delaware. Inari agreed to destroy Corteva material accessed through seed depositories, together with material develo ...
Corteva clears SEC registration milestone for Vylor separation
Corteva ($CTVA) said the SEC declared Vylor’s Form 10 registration statement effective, advancing the planned separation of its seed and genetics business. Eligible Corteva shareholders are scheduled to receive one Vylor share for each Cort ...
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...
